My advice to you would be to wait until TROW drops a few points during the next market dip (there will be one soon) and then buy.
Only don't expect the shares to decline significantly. You may also wish to wait until the shares are split two for one next April. Usually, after a split there is usually some profit taking and you may be able to get in at a better price --but there are no guarantees.
Very interesting. Thank you, Spin2000. I guess that's a major factor in the stock's heavy trading. Fortunately for us, there are more buyers than sellers.
Does anyone know anything about this Allhusen appointment? Evidently, some investors are impressed. Does anyone know anything about this gentleman's track record at Advanta?
<<<Has anyone noticed the volume that is being traded on BDX? Am I mistaking, or has it been three times average volume. Seems unusal. >>>
I've noticed too that the volume has been two or three times the norm lately. I'm wondering what's going on...
This is a response to Evansgeo's post of 1/21. No, I haven't lost faith in the company, but after last year's dismal
performance I needed to vent my frustrations. Nevertheless, I haven't considered dumping the stock. I am pleased that earnings for the
recent quarter showed a healthy profit and that shares (today) broke through the 60's range. I still have strong reservations about
how the company expects to achieve its ambitious growth plans without seeking some new (non-traditional) niche for faster
growth, perhaps via a major acquisition. I remain skeptical, but appreciate that the stock is beginning to move. I only hope this
upward tick is not a flash in the pan with the stock later dropping back into familiar 40's-50's territory. I've seen that happen
many times before.
I am ECSTATIC --that's the word-- about BDX's new strength. I only hope it will not be a flash in the pan. A few times last year, the stock went up like this and then fell back and stayed down. I really hope this time the rise will be permanent.
I agree with post #11. We ought to stay in touch and share information on BDX. This company is not very popular in the message boards. I started a board in the Motley Fool and no one posts but me. I also agree that BDX has gone nowhere since 1996. Growth during 97 was negligible. I don't want to dump the shares because I still have faith on the CEO. Let's hope he'll keep his word. Good luck to you all.
I appreciate your response, but how do you suppose the CEO is going to double the company's business in 3 years when their medical supplies and devices division has been scraping by for the past several years with essentially static growth. Only their diagnostic division is doing slightly better, but they derive a larger share of their revenues from supplies and devices.
The Difco and PharMingen acquisitions were nice (though small) acquisitions and should add to the bottom line, but not significantly. After all their aggregate revenues for 1997 were a paltry $117 million, which is a drop in the bucket.
Clateo's master plan is to promote faster growth by focusing on the company's human resources and foster improved communication and collaboration among them. I know this isn't enough. I think he is going to have to make bolder moves to realize his growth strategy.
Picker, I agree with every word you wrote. BDX had been one of the best stocks in my portfolio up until 12/96. This year
their growth has stalled. The CEO seems very indecisive and does not appear to have a well-defined strategy to enhance shareholder
value. 1998 is going to be the same as 1997 = growth equal to zero or in the single digits. I've just received their annual report,
and the CEO's message to the shareholders is vague and full of platitudes. Things like "the power of individual initiative..."
and how "people resources...are the most critical... and how important it is to "achieve their fullest potential..." and "we
must improve communication..." and all that baloney, but there is nothing specific on how they plan to move decisively to promote
growth and move the company away from the status quo.
I am planning to attend the shareholder meeting if I am able to arrange to reach the site by public transportation. If not, I will write a letter to the CEO to make my views known. I am not sure this will do much since I am only a single voice, but I have a burning desire to get a few things off my chest.
I called the company this morning and spoke to a shareholders' relations representative. The company is very much aware of the sharp decline in its stock. They attribute it to "year-end institutional selling" and nothing more. I was assured that there is nothing inherently wrong with the company. They stand behind their CEO's press release of 12/8/97 and maintain that the worst case scenario for 1998 would be a dividend reduction no lower than 55 cents.
For what it's worth, I just paid a visit to CMO's home page and they had a link for "shareholder information" which included
their press releases (their last is dated 12/8/97 and is the one we all know about). They also have a link for "analysts' research
reports," which is supposed to be up-to-date. Well, it isn't. They had three reports from three firms --one of them Paine Webber--
issued last spring or earlier, which rate the company as a "buy." CMO has chosen not to post the more recent Paine Webber analysis
dated 12/8/97 in which the brokerage firm downgraded CMO from "attractive" to "neutral." The moral of this story is that CMO's
home page does not depict the company's current true picture. They appear to make public the good news and disregard the bad. I
find that unethical and makes me wonder whether this management is entirely trustworthy.